Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Acquisitions: 2015-2023

  • Fortress Biotech's Acquisitions rose 75.00% to -$5.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was -$24.8 million, marking a year-over-year decrease of 25.36%. This contributed to the annual value of -$20.0 million for FY2022, which is N/A change from last year.
  • Per Fortress Biotech's latest filing, its Acquisitions stood at -$5.0 million for Q1 2023, which was up 75.00% from -$20.0 million recorded in Q1 2022.
  • Fortress Biotech's Acquisitions' 5-year high stood at -$5.0 million during Q1 2023, with a 5-year trough of -$20.0 million in Q1 2022.
  • In the last 2 years, Fortress Biotech's Acquisitions had a median value of -$12.5 million in 2022 and averaged -$12.5 million.
  • Data for Fortress Biotech's Acquisitions shows a peak YoY surged of 75.00% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Fortress Biotech's Acquisitions stood at -$20.0 million in 2022, then skyrocketed by 75.00% to -$5.0 million in 2023.
  • Its last three reported values are -$5.0 million in Q1 2023, -$20.0 million for Q1 2022, and $63,000 during Q2 2018.